Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …
Read the full story »This slide by presented by Daniel Hawkins in the MM&M podcast clearly shows why there will soon no longer be a distinction between originator pharma and generic companies. Not many words needed.
Although we’ve seen a huge increase in the number of clients going straight to purchasing white-label formulations products, basically the switch for European generics companies from manufacturing to marketing, CEE markets still have low manufacturing …
Leave a comment!